Phase 2 study

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Immunovant Sciences GmbH
Registry number NCT07018323
Started 19 June 2025 Today 16 October 2026 Estimated completion 1 May 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Site Number - 5105 Sydney NSW Recruiting
Site Number - 5103 Warrawong NSW Recruiting
Site Number - 5101 Brisbane QLD Recruiting
Site Number - 5107 Douglas QLD Recruiting
Site Number - 5100 Southport QLD Recruiting
Site Number - 5102 Box Hill VIC Recruiting
Site Number - 5104 Geelong VIC Recruiting
Site Number - 5110 Parkville VIC Recruiting
Site Number - 5108 Perth WA Recruiting
Site Number - 5109 Saint Leonards NSW Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 75 Years
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 210

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Participants with the ability to understand the requirements of the trial, provide written informed consent, and comply with the trial protocol procedures.

* Male or female participants aged ≥ 18 years.

* Participants with diagnosis of GD who are hyperthyroid despite ATD treatment.

* Other, more specific inclusion criteria are defined in the protocol.

Exclusion Criteria:

* Have previously been successfully treated with radioactive iodine (RAI) therapy or have undergone total thyroidectomy.

* Have an autoimmune disease other than GD requiring treatment that, in the Investigator's judgment, puts the participant at undue risk.

* Have moderate-to-severe active thyroid eye disease (TED) and are expected to require immediate surgical intervention and/or are planning corrective surgery/irradiation or medical therapy for TED during study participation.

* Additional exclusion criteria are defined in the protocol.

Dates on the record

Started 19 June 2025
Estimated completion 1 May 2027
Registry last updated 25 August 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 25 August 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.